Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 5 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.


Player Avatar dabyrdman (< 20) Submitted: 11/30/2012 3:01:05 PM : Underperform Start Price: $65.79 JNJ Score: -16.52

Nothing that I would bet against the company itself, I just feel the stock price is too inflated to beat the market unless somehow they make leaps and bounds on cash flow (which, given their current size, is practically impossible). I don't feel the stock over the long term will lose money, just that it will lose money comparatively to the market.

Member Avatar BlaKvestments (< 20) Submitted: 2/27/2013 2:14:39 PM
Recs: 0

So you think they've peaked for now, in a way?

Featured Broker Partners